302 related articles for article (PubMed ID: 25440627)
21. Routine Intraoperative Inhaled Milrinone and Iloprost Reduces Inotrope Use in Patients Undergoing Cardiac Surgery: A Retrospective Cohort Pilot Study.
Hu X; Li X; Boggett S; Yang Y; Chun-Ting W; Anstey J; Royse A; Royse C
Anesth Analg; 2020 Aug; 131(2):527-536. PubMed ID: 32371741
[TBL] [Abstract][Full Text] [Related]
22. Combined usage of inhaled and intravenous milrinone in pulmonary hypertension after heart valve surgery.
Carev M; Bulat C; Karanović N; Lojpur M; Jercić A; Nenadić D; Marovih Z; Husedzinović I; Letica D
Coll Antropol; 2010 Sep; 34(3):1113-7. PubMed ID: 20977113
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.
Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P
J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102
[TBL] [Abstract][Full Text] [Related]
24. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
25. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial.
Rex S; Schaelte G; Metzelder S; Flier S; de Waal EE; Autschbach R; Rossaint R; Buhre W
Acta Anaesthesiol Scand; 2008 Jan; 52(1):65-72. PubMed ID: 17976224
[TBL] [Abstract][Full Text] [Related]
26. Inhaled prostacyclin reduces cardiopulmonary bypass-induced pulmonary endothelial dysfunction via increased cyclic adenosine monophosphate levels.
Fortier S; DeMaria RG; Lamarche Y; Malo O; Denault A; Desjardins F; Carrier M; Perrault LP
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):109-16. PubMed ID: 15224029
[TBL] [Abstract][Full Text] [Related]
27. Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series.
Enderby CY; Soukup M; Al Omari M; Zeiger T; Burger C
J Clin Pharm Ther; 2014 Oct; 39(5):496-500. PubMed ID: 24806480
[TBL] [Abstract][Full Text] [Related]
28. Dobutamine and Nitroglycerin Versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery. A Randomized Controlled Study.
Eskandr AM; Metwally AA; Abu Elkassem MS; Sadik SA; Elmiligy AE; Mourad M; Hussein L
J Cardiothorac Vasc Anesth; 2018 Dec; 32(6):2540-2546. PubMed ID: 29880427
[TBL] [Abstract][Full Text] [Related]
29. Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial.
Winterhalter M; Simon A; Fischer S; Rahe-Meyer N; Chamtzidou N; Hecker H; Zuk J; Piepenbrock S; Strüber M
J Cardiothorac Vasc Anesth; 2008 Jun; 22(3):406-13. PubMed ID: 18503929
[TBL] [Abstract][Full Text] [Related]
30. Inhaled milrinone in cardiac surgical patients: a pilot randomized controlled trial of jet vs. mesh nebulization.
Nguyen AQ; Denault AY; Théoret Y; Perrault LP; Varin F
Sci Rep; 2020 Feb; 10(1):2069. PubMed ID: 32034202
[TBL] [Abstract][Full Text] [Related]
31. A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients.
Denault AY; Bussières JS; Arellano R; Finegan B; Gavra P; Haddad F; Nguyen AQN; Varin F; Fortier A; Levesque S; Shi Y; Elmi-Sarabi M; Tardif JC; Perrault LP; Lambert J
Can J Anaesth; 2016 Oct; 63(10):1140-1153. PubMed ID: 27470232
[TBL] [Abstract][Full Text] [Related]
32. Inhaled prostacyclin (PGI2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit.
Haché M; Denault AY; Bélisle S; Couture P; Babin D; Tétrault F; Guimond JG
Can J Anaesth; 2001 Oct; 48(9):924-9. PubMed ID: 11606352
[TBL] [Abstract][Full Text] [Related]
33. The Effect of Inhaled Milrinone Versus Inhaled Levosimendan in Pulmonary Hypertension Patients Undergoing Mitral Valve Surgery - A Pilot Randomized Double-Blind Study.
Kundra TS; Prabhakar V; Kaur P; Manjunatha N; Gandham R
J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2123-2129. PubMed ID: 30098861
[TBL] [Abstract][Full Text] [Related]
34. Comparison of inhaled nitric oxide with aerosolized prostacyclin or analogues for the postoperative management of pulmonary hypertension: a systematic review and meta-analysis.
Chen SH; Chen LK; Teng TH; Chou WH
Ann Med; 2020; 52(3-4):120-130. PubMed ID: 32204626
[No Abstract] [Full Text] [Related]
35. Effects of low-dose milrinone on weaning from cardiopulmonary bypass and after in patients with mitral stenosis and pulmonary hypertension.
Oztekin I; Yazici S; Oztekin DS; Goksel O; Issever H; Canik S
Yakugaku Zasshi; 2007 Feb; 127(2):375-83. PubMed ID: 17268158
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.
Melnick L; Barst RJ; Rowan CA; Kerstein D; Rosenzweig EB
Am J Cardiol; 2010 May; 105(10):1485-9. PubMed ID: 20451700
[TBL] [Abstract][Full Text] [Related]
37. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
38. A Comparison of Inhaled Nitric Oxide Versus Inhaled Epoprostenol for Acute Pulmonary Hypertension Following Cardiac Surgery.
McGinn K; Reichert M
Ann Pharmacother; 2016 Jan; 50(1):22-6. PubMed ID: 26438636
[TBL] [Abstract][Full Text] [Related]
39. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
40. The successful management of severe protamine-induced pulmonary hypertension using inhaled prostacyclin.
Jerath A; Srinivas C; Vegas A; Brister S
Anesth Analg; 2010 Feb; 110(2):365-9. PubMed ID: 19933533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
